Skip to main navigation Skip to search Skip to main content

Rebuttal letter on “Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature”

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)2107-2108
Number of pages2
JournalClinical Rheumatology
Volume40
Issue number5
DOIs
StatePublished - May 2021

Funding

Financial support from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ), Brasil – Grants 308429/2018-4 and 405661/2018-5

FundersFunder number
Conselho Nacional de Desenvolvimento Científico e Tecnológico308429/2018-4, 405661/2018-5

    ASJC Scopus subject areas

    • Rheumatology

    Cite this